Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

NCT02376452 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Carcinoma

Interventions

DRUG: Raltitrexed
DRUG: Irinotecan
DRUG: 5-fluorouracil
DRUG: Leucovorin

Sponsor

Fudan University